Navigation Links
Zimmer Holdings Offer and ORTHOsoft Directors' Circular Mailed to Shareholders
Date:9/7/2007

WARSAW, Ind. and MONTREAL, Sept. 7 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedics industry, and ORTHOsoft Inc. (TSX-Venture: OSH), a leader in computer navigation for orthopaedic surgery, announced that Zimmer's indirect wholly owned subsidiary, ZMH Acquisition Co., has mailed today its offer and circular to ORTHOsoft shareholders in connection with Zimmer's previously announced takeover bid for all of ORTHOsoft's outstanding common shares in a cash transaction for CDN$1.10 per common share (the "Offer"). The ORTHOsoft Directors' Circular was also mailed with the Offer.

The Offer is open for acceptance until 6:00 p.m. (Eastern time) on October 15, 2007, unless withdrawn or extended, and is subject to customary closing conditions including, among other things, that the number of ORTHOsoft common shares being validly deposited under the Offer and not withdrawn, upon expiration of the Offer, constitute, together with any common shares directly or indirectly held by ZMH Acquisition Co. and its affiliates, at least 66-2/3% of the common shares calculated on a fully diluted basis and more than 50% of the common shares calculated on a fully diluted basis, the votes attached to which would be included in the minority approval of a second-step business combination.

ORTHOsoft shareholders are advised to read the Offer, the Directors' Circular and related documents, which have been filed with the Canadian securities regulatory authorities, as they contain important information. ORTHOsoft shareholders may obtain a copy of these materials at http://www.sedar.com.

About Zimmer

Founded in 1927 and headquartere
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Wrinkle reduction cream has offered insights into working of nervous system
5. Magnesium sulfate offers no help in migraine treatment
6. Drug Offers Hope for Alzheimers disease
7. Drug Firm Offers to Donate Smallpox Vaccine
8. Stem cells offer hope for muscular dystrophy
9. Stem Cells Found To Offer Promise For Hair Growth
10. fMRI Offers Insight Into An Infants Brain
11. Diet Found To Offer Protection Against Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2008)...ewswire/ -- Many baby boomers,incorrectly believe ...to a,new survey conducted by Harris Interactive(R)...IP). Most say that disability insurance is importa...ey do not have any disability,income protection., ...830/AHIPLOGO ), "Baby boomers recognize the valu...
(Date:5/22/2008)...nt for Adult Acne Sufferers, LOS ANGELES, May 22 ...ewed as a teenage "rite of passage," results from ...ow that acne is a problem that also,commonly affec...ly impact,many aspects of a person,s life -- profe...sic lack of knowledge may be preventing or hinderi...
(Date:5/22/2008)...Fat Compartment Essential to Facial,Rejuvenation, ...IGHTS, Ill., May 22 /PRNewswire-USNewswire/ - Not ...entral to the American concept of,beauty. A study ...he,official medical journal of the American Societ...t compartment located within the cheek is vital,to...
(Date:5/22/2008)... Of Its Summer-Long Harley-Davidson ...EE, May 22 /PRNewswire/ -- Miller Brewing Company ...ociation (MDA) for every Miller Lite,bottle cap co...brand,s,"Better. Bolder. Summer" promotion. Miller...beer sponsor of this summer,s Harley-Davidson 105t...
Breaking Medicine News(10 mins):Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 2Health News:Many Baby Boomers Incorrectly Believe They Are Protected Against the Risk of Disability 3Health News:Acne - Not Just a Teen Issue 2Health News:Acne - Not Just a Teen Issue 3Health News:Acne - Not Just a Teen Issue 4Health News:Acne - Not Just a Teen Issue 5Health News:Acne - Not Just a Teen Issue 6Health News:Key to Angelina-Like Cheeks? Add Volume to Deep Fat Compartment 2Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 2Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 3
... five more victims in Bataan, Rizal and Marikina C...alenzuela City and a four-and-a-half child from Ba...r. Ricardo Lustre, administrator of the Amang Rodr...ild was at “critical stage 4,” and died 10 hours a...
...atives to combat tropical diseases that ails many ...tin America//, was given a renewed thrust by The B...ur grants totaling to more than $68.2 million. Th...ee diseases - hookworm, leishmaniasis and trypanos...
... star Wayne Rooney, Coleen McLoughlin launched Chi...d her desire to raise awareness of the work hospic... funds.// Coleen, 20, has personal experience to s...Rosie, suffers from genetic disorder Rett Syndrome...
...iew that was published in the Friday’s issue of th...kids does not reduce their risk of fractures in th...f the maximum bone mass is got by the age of 18 ye...ng bone mass at an early age might reduce the effe...
Other Medicine News:
(Date:5/21/2008)...First Presentation of Full Data Set from the TRIUM... Treprostinil, SILVER SPRING, Md., May 21 /PRNews... (Nasdaq: UTHR ) and its wholly-owned subsidiary,... presentations concerning,the treatment of pulmona...ere reported at the American Thoracic Society (ATS...
(Date:5/21/2008)... Innovative pipeline products highlight Watson,s c...oed Until 2:10 PM EDT, ORLANDO, Fla., May 21 /PRN... (NYSE: WPI ), a leading specialty pharmaceutical...nted clinical data on two Phase 3 products at,the ...The abstracts include,a cardiac safety trial invol...
(Date:5/21/2008)... Tumor responses, safety and long-term survivors...h product approach, SAN FRANCISCO and YONGIN-SI, ... (San Francisco, CA and Ottawa, Ontario), and its ...today that Phase I clinical,trial results from its... in,the premier journal Lancet Oncology. The major...
(Date:5/21/2008)... Findings Show Cystic Fibrosis Patients Cough More... -, SOUTH PLAINFIELD, N.J., May 21 /PRNews...ced new data suggesting that the quantification of... outcome measure in cystic,fibrosis (CF). Cough is...related symptoms in CF. According to data presente...
Breaking Medicine Technology:Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 2Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 3Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 4Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 5Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder 6Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 2Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 3Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology 4PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4YouTube Video to Benefit AIDS Babies 4653 1CNA Presents New Data on Sutters Medical Redlining 4650 1CNA Presents New Data on Sutters Medical Redlining 4650 2CNA Presents New Data on Sutters Medical Redlining 4650 3Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 1Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 2Sigma Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 1515 3Hospital Romance May Largely Be Fiction 4649 1Hospital Romance May Largely Be Fiction 4649 2Hospital Romance May Largely Be Fiction 4649 3
...- Forest,Laboratories, Inc. and PAION AG today ann... In Acute Ischemic Stroke) study with the,compound...,investigate the improvement of clinical outcome i... Desmoteplase within 3 to 9 hours,after onset of s...,efficacy endpoint (difference between active trea...
... Research,collaborators with Oncolytics Biotech In...r presentation covering REOLYSIN(R),clinical trial...,(ASCO) Annual Meeting, to be held June 1-5, 2007 ...tics, U.K. Phase I systemic,administration trial. ... Study of,Wild-Type Oncolytic Reovirus Administere...
Other Medicine Technology:Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Topline Results of Phase III Study in Acute Ischemic Stroke,(Dias-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4Oncolytics Biotech Inc.'s Research Collaborators to Present,REOLYSIN Clinical Trial Data at ASCO Conference 2
Lumitex® LightMat® Surgical Illuminator improves visualization in deep cavity surgery. Flexible and malleable, it attaches easily to most retractors, bringing bright, cool area lighting where
...HELION family consists of four models in proven ha...ure you find the right solution for every applicat... of two or three mobile lamps also battery-powered...h on the lamp housing, the standard-plus models of...
The Sunnex Celestial Star™ light is ideal for surgical applications. The flexible design allows for easy angling and positioning. The space-saving structure is ideal for many facilities includi
... new small incision surgical light is an industry ... for many surgeons. The DeepSite provides 10,000-f...hes, and can be positioned with one hand at distan...t is not tethered to the surgeon, so it allows tot...
Medicine Products: